Abivax ADR
Abivax ADR (ABVX) Wheel Strategy
ABVX wheel strategy scan found 140 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 282.4%.
Read more
Running a ABVX wheel strategy lets you generate consistent premium income on Abivax ADR while setting your own entry and exit prices on the underlying. Abivax ADR's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own ABVX, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best ABVX wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on ABVX, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable ABVX wheel from a losing one.
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer.
In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the ABVX wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your ABVX wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Sep 25, 2026 | 98.00 | $0.75 | $2.28 | -0.47 | 3 | 16% | 51.2% | 282.4% | 37 |
| Sep 25, 2026 | 97.00 | $0.25 | $1.93 | -0.41 | 3 | 16% | 58.5% | 241.5% | 55 |
| Sep 25, 2026 | 95.00 | $0.40 | $1.30 | -0.30 | 3 | 16% | 72.2% | 166.5% | 564 |
| Oct 2, 2026 | 97.00 | $2.40 | $4.00 | -0.43 | 10 | 16% | 53.3% | 150.5% | 3 |
| Sep 25, 2026 | 94.00 | $0.70 | $1.10 | -0.25 | 3 | 16% | 78.2% | 142.4% | 4 |
| Oct 2, 2026 | 96.00 | $1.70 | $3.40 | -0.39 | 10 | 16% | 57.2% | 129.3% | 12 |
| Oct 9, 2026 | 97.00 | $3.30 | $4.85 | -0.43 | 17 | 16% | 51.6% | 107.4% | 3 |
| Sep 25, 2026 | 91.00 | $0.05 | $0.75 | -0.17 | 3 | 16% | 91.3% | 100.3% | 9 |
| Oct 9, 2026 | 96.00 | $2.60 | $4.30 | -0.40 | 17 | 16% | 54.5% | 96.2% | 0 |
| Oct 2, 2026 | 94.00 | $0.85 | $2.38 | -0.32 | 10 | 16% | 64.8% | 92.2% | 0 |
As of September 25, 2026
Run the Wheel on ABVX With Confidence
Find the best ABVX wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→